A highly conserved cryptic epitope in the receptor binding domains of SARS-CoV-2 and SARS-CoV

Science
Meng YuanIan A Wilson

Abstract

The outbreak of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2) has now become a pandemic, but there is currently very little understanding of the antigenicity of the virus. We therefore determined the crystal structure of CR3022, a neutralizing antibody previously isolated from a convalescent SARS patient, in complex with the receptor binding domain (RBD) of the SARS-CoV-2 spike (S) protein at 3.1-angstrom resolution. CR3022 targets a highly conserved epitope, distal from the receptor binding site, that enables cross-reactive binding between SARS-CoV-2 and SARS-CoV. Structural modeling further demonstrates that the binding epitope can only be accessed by CR3022 when at least two RBDs on the trimeric S protein are in the "up" conformation and slightly rotated. These results provide molecular insights into antibody recognition of SARS-CoV-2.

References

Feb 26, 2004·Proceedings of the National Academy of Sciences of the United States of America·Jianhua SuiWayne A Marasco
Jul 6, 2004·Journal of Virological Methods·Jody D BerryFrank Plummer
Dec 2, 2004·Acta Crystallographica. Section D, Biological Crystallography·Paul Emsley, Kevin Cowtan
Nov 23, 2005·Bioinformatics·Konstantin ArnoldTorsten Schwede
Apr 7, 2006·The Journal of Biological Chemistry·Ponraj PrabakaranDimiter S Dimitrov
Sep 7, 2006·The Journal of Biological Chemistry·William C HwangRobert C Liddington
Aug 8, 2007·Journal of Molecular Biology·Evgeny Krissinel, Kim Henrick
Feb 4, 2010·Acta Crystallographica. Section D, Biological Crystallography·Paul D AdamsPeter H Zwart
Jul 9, 2011·Science·Damian C EkiertJaap Goudsmit
Aug 11, 2012·Science·Cyrille DreyfusRobert H E Friesen
May 15, 2013·Nucleic Acids Research·Jian YeJames M Ostell
Mar 19, 2014·Proteins·Alexey TeplyakovGary L Gilliland
Nov 10, 2015·Nature Medicine·Vineet D MenacheryRalph S Baric
Mar 16, 2016·Proceedings of the National Academy of Sciences of the United States of America·Vineet D MenacheryRalph S Baric
Jan 1, 1997·Methods in Enzymology·Zbyszek Otwinowski, Wladek Minor
Feb 23, 2020·Science·Daniel WrappJason S McLellan
Mar 4, 2020·Nature Microbiology·UNKNOWN Coronaviridae Study Group of the International Committee on Taxonomy of Viruses
Mar 11, 2020·Cell·Alexandra C WallsDavid Veesler

❮ Previous
Next ❯

Citations

May 20, 2020·Journal of Clinical Medicine·Umesh KalathiyaJavier Antonio Alfaro
May 5, 2020·Microbial Biotechnology·Harald Brüssow
May 7, 2020·International Journal of Clinical Practice·Manuel Becerra-Flores, Timothy Cardozo
Apr 19, 2020·Journal of Virology·Austin NguyenReid F Thompson
May 22, 2020·European Journal of Immunology·Huibin LvChris K P Mok
May 16, 2020·Indian Journal of Pediatrics·Nitin DhochakRakesh Lodha
May 18, 2020·The FEBS Journal·Alexander WlodawerMariusz Jaskolski
Jul 18, 2020·PLoS Medicine·Francesco PinottiVittoria Colizza
Jun 10, 2020·American Journal of Physiology. Cell Physiology·Guangdong Yang
May 24, 2020·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Frederick S BucknerH Nina Kim
Jun 20, 2020·Nature·Davide F RobbianiMichel C Nussenzweig
Jun 28, 2020·The Journal of Immunology : Official Journal of the American Association of Immunologists·Wafaa B AlsoussiAli H Ellebedy
Sep 6, 2020·Nucleic Acids Research·Ragul GowthamanBrian G Pierce
Sep 10, 2020·PloS One·Lluc Farrera-SolerNicolas Winssinger
Jul 15, 2020·Nature Structural & Molecular Biology·Jiandong HuoJames H Naismith
May 22, 2020·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Wei GuCharles Y Chiu
Jun 23, 2020·Indian Journal of Pharmacology·Manisha PrajapatBikash Medhi
Jun 12, 2020·Nature Communications·Yi Zhang, Tatiana G Kutateladze
Aug 9, 2020·Proceedings of the National Academy of Sciences of the United States of America·Yuan-Lin KangTom Kirchhausen
Jul 9, 2020·Frontiers in Pharmacology·Colin D FunkAli Ardakani
Jul 24, 2020·Nature Structural & Molecular Biology·Rory HendersonPriyamvada Acharya
Sep 11, 2020·Nature Microbiology·Wen Shi LeeBrandon J DeKosky
Aug 2, 2020·Nature Structural & Molecular Biology·Xiaoli XiongJohn A G Briggs
Aug 25, 2020·Advanced Science·Yetian DongFangfang Zhou
Jul 3, 2020·Cell Research·Bao-Zhong ZhangJian-Dong Huang
Jul 17, 2020·Wiley Interdisciplinary Reviews. Nanomedicine and Nanobiotechnology·Marina A Dobrovolskaia, Mark Bathe
May 18, 2020·Nature Reviews. Microbiology·Nawsad Alam, Matthew K Higgins

❮ Previous
Next ❯

Methods Mentioned

BETA
enzyme-linked immunosorbent assay
ELISA

Software Mentioned

IgBlast

Related Concepts

Related Feeds

Antibody Specificity

Antibodies produced by B cells are highly specific for antigen as a result of random gene recombination and somatic hypermutation and affinity maturation. As the main effector of the humoral immune system, antibodies can neutralize foreign cells. Find the latest research on antibody specificity here.